Clinical Trial to Evaluate the Efficacy and Safety of DW4902

NCT07319520 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Myoma of Uterus

Interventions

DRUG: DW4902 Placebo
DRUG: DW4902 160mg
DRUG: DW4902 240mg
DRUG: DW4902 320mg

Sponsor

Daewon Pharmaceutical Co., Ltd.